0001599901424B5EX-FILING FEESS-3S-3 0001599901 2024-08-09 2024-08-09 0001599901 1 2024-08-09 2024-08-09 0001599901 1 2024-08-09 2024-08-09 0001599901 2 2024-08-09 2024-08-09 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Table
Form
S-3
(Form Type)
Avidity Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                 
    
Security
Type
  
Security
Class
Title
  
Fee
Calculation
or Carry
Forward
Rule
  
Amount
Registered
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
  
Amount
of
Registration
Fee
 
Newly Registered Securities
                 
Fees to Be
Paid
   Equity   Common Stock, par value
0.0001 per share		   Rule 457(o)(1)    $400,000,000     $400,000,000   0.00014760   $59,040
                 
Fees
Previously
Paid
   —    —    —    —    —    —    —    — 
           
   
Total Offering Amounts 
     $400,000,000     $59,040
           
   
Total Fees Previously Paid 
     $
0
     $0
           
   
Total Fee Offsets 
         $14,582
           
   
Net Fee Due 
               $44,458
 
(1)
Calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”) based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. Payment of the registration fee at the time of filing of the registrant’s Registration Statement on Form
S-3
(File
No. 333-279264)
on May 9, 2024 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith.
Table 2: Fee Offset Claims and Sources
 
                       
    
Registrant
or Filer
Name
  
Form
or
Filing
Type
  
File
Number
  
Initial
Filing
Date
  
Filing
Date
  
Fee
Offset
Claimed
  
Security
Type
Associated
with Fee
Offset
Claimed
  
Security
Title
Associated
with Fee
Offset
Claimed
  
Unsold
Securities
Associated
with Fee
Offset
Claimed
  
Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed
  
Fee Paid
with Fee
Offset
Source
 
Rule 457(p)
                       
Fee Offset
Claims
   Avidity
Biosciences,
Inc.		  
424(b)(5)
  
333-257691
   November 8, 2022     $14,582   Equity   Common
Stock		   (1)   $132,330,608    
                       
Fee-Offset

Sources
   Avidity
Biosciences,
Inc.		  
424(b)(5)
  
333-257691
       November 8, 2022                       $14,582
 
(1)
In connection with the registration of the offering of up to $200,000,000 of shares of common stock, including the Unsold Shares (as defined below) under the prospectus supplement, dated November 8, 2022 (the “Prior Prospectus”), to the Registration Statement on Form
S-3
(Registration
No. 333-257691),
which was filed with the Securities and Exchange Commission (the “SEC”) on July 2, 2021 (the “Prior Registration Statement”), the Registrant paid registration fees of $22,040, based on the filing fee then in effect. Of those shares of common stock, shares having an aggregate offering price of $67,669,392 were sold, and shares of common stock having an aggregate offering price of $132,330,608 were unsold (the “Unsold Shares”). The offering made under the Prior Prospectus and the Prior Registration Statement has been terminated. $14,582 is the portion of the registration fee associated with the Unsold Shares that is due under this prospectus supplement using all of the previously paid but unused registration fees associated with the Prior Prospectus and the Prior Registration Statement. Accordingly, a filing fee of $44,458 is being paid herewith.